Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1991 1
1999 1
2000 11
2001 4
2002 1
2003 7
2004 1
2005 4
2006 3
2007 6
2008 12
2009 8
2010 16
2011 8
2012 26
2013 26
2014 30
2015 41
2016 50
2017 46
2018 58
2019 40
2020 64
2021 77
2022 59
2023 67
2024 19

Text availability

Article attribute

Article type

Publication date

Search Results

623 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Pulmonary fibrosis and/or bone marrow failure, telomere-related, 6"
Page 1
The effectiveness of the active cycle of breathing technique in patients with chronic respiratory diseases: A systematic review.
Zisi D, Chryssanthopoulos C, Nanas S, Philippou A. Zisi D, et al. Heart Lung. 2022 May-Jun;53:89-98. doi: 10.1016/j.hrtlng.2022.02.006. Epub 2022 Feb 27. Heart Lung. 2022. PMID: 35235877 Review.
This systematic review provides an update on the new related studies, expanding the evidence base through the last 12 years and specifically evaluating the effectiveness of ACBT on pulmonary function-related outcome variables in patients with chronic respiratory diseases. …
This systematic review provides an update on the new related studies, expanding the evidence base through the last 12 years and specifically …
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
Hutchinson J, Fogarty A, Hubbard R, McKeever T. Hutchinson J, et al. Eur Respir J. 2015 Sep;46(3):795-806. doi: 10.1183/09031936.00185114. Epub 2015 May 14. Eur Respir J. 2015. PMID: 25976683 Free article. Review.
As idiopathic pulmonary fibrosis emerges as an important public health problem, there is a need to coordinate data on incidence and mortality globally. ...The majority of studies showed an increase in incidence over time.The incidence of idiopathic pulmonary …
As idiopathic pulmonary fibrosis emerges as an important public health problem, there is a need to coordinate data on incidenc …
Pulmonary rehabilitation for interstitial lung disease.
Dowman L, Hill CJ, May A, Holland AE. Dowman L, et al. Cochrane Database Syst Rev. 2021 Feb 1;2(2):CD006322. doi: 10.1002/14651858.CD006322.pub4. Cochrane Database Syst Rev. 2021. PMID: 34559419 Free PMC article. Review.
We specified a priori subgroup analyses for participants with idiopathic pulmonary fibrosis (IPF) and participants with severe lung disease (low diffusing capacity or desaturation during exercise). ...AUTHORS' CONCLUSIONS: Pulmonary rehabilitation can be perf …
We specified a priori subgroup analyses for participants with idiopathic pulmonary fibrosis (IPF) and participants with severe …
Pirfenidone in Progressive Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
Ghazipura M, Mammen MJ, Bissell BD, Macrea M, Herman DD, Hon SM, Kheir F, Khor YH, Knight SL, Raghu G, Wilson KC, Hossain T. Ghazipura M, et al. Ann Am Thorac Soc. 2022 Jun;19(6):1030-1039. doi: 10.1513/AnnalsATS.202103-342OC. Ann Am Thorac Soc. 2022. PMID: 35499847
Objective: To conduct a systematic review to evaluate existing ILD literature to determine whether patients with progressive pulmonary fibrosis (PPF) should be treated with the antifibrotic pirfenidone. ...Meta-analyses revealed that changes in forced vital capacity …
Objective: To conduct a systematic review to evaluate existing ILD literature to determine whether patients with progressive pulmonary …
JAK inhibitors and systemic sclerosis: A systematic review of the literature.
Moriana C, Moulinet T, Jaussaud R, Decker P. Moriana C, et al. Autoimmun Rev. 2022 Oct;21(10):103168. doi: 10.1016/j.autrev.2022.103168. Epub 2022 Aug 6. Autoimmun Rev. 2022. PMID: 35944611 Review.
BACKGROUND: Systemic sclerosis (SSc) is a systemic autoimmune disease with heterogeneous clinical presentation and prognosis. JAK inhibitors reduced cutaneous and pulmonary fibrosis in mice models of SSc. Clinical data regarding the efficacy and safety of JAK inhibi …
BACKGROUND: Systemic sclerosis (SSc) is a systemic autoimmune disease with heterogeneous clinical presentation and prognosis. JAK inhibitors …
Nintedanib in Progressive Pulmonary Fibrosis: A Systematic Review and Meta-Analysis.
Ghazipura M, Mammen MJ, Herman DD, Hon SM, Bissell BD, Macrea M, Kheir F, Khor YH, Knight SL, Raghu G, Wilson KC, Hossain T. Ghazipura M, et al. Ann Am Thorac Soc. 2022 Jun;19(6):1040-1049. doi: 10.1513/AnnalsATS.202103-343OC. Ann Am Thorac Soc. 2022. PMID: 35499854
Objective: To conduct a systematic review to evaluate existing ILD literature to determine whether patients with progressive pulmonary fibrosis (PPF) should be treated with the antifibrotic nintedanib. ...The annual decline in forced vital capacity was less in the n …
Objective: To conduct a systematic review to evaluate existing ILD literature to determine whether patients with progressive pulmonary …
Efficacy of antifibrotic drugs, nintedanib and pirfenidone, in treatment of progressive pulmonary fibrosis in both idiopathic pulmonary fibrosis (IPF) and non-IPF: a systematic review and meta-analysis.
Finnerty JP, Ponnuswamy A, Dutta P, Abdelaziz A, Kamil H. Finnerty JP, et al. BMC Pulm Med. 2021 Dec 11;21(1):411. doi: 10.1186/s12890-021-01783-1. BMC Pulm Med. 2021. PMID: 34895203 Free PMC article.
BACKGROUND: Research questions To compare the efficacy of nintedanib and pirfenidone in the treatment of progressive pulmonary fibrosis; and to compare the efficacy of anti-fibrotic therapy (grouping nintedanib and pirfenidone together) in patients with IPF versus p …
BACKGROUND: Research questions To compare the efficacy of nintedanib and pirfenidone in the treatment of progressive pulmonary fib …
Medical treatments for idiopathic pulmonary fibrosis: a systematic review and network meta-analysis.
Pitre T, Mah J, Helmeczi W, Khalid MF, Cui S, Zhang M, Husnudinov R, Su J, Banfield L, Guy B, Coyne J, Scallan C, Kolb MR, Jones A, Zeraatkar D. Pitre T, et al. Thorax. 2022 Dec;77(12):1243-1250. doi: 10.1136/thoraxjnl-2021-217976. Epub 2022 Feb 10. Thorax. 2022. PMID: 35145039
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a respiratory disorder with a poor prognosis. ...
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a respiratory disorder with a poor prognosis. ...
Physical exercise training for cystic fibrosis.
Radtke T, Nevitt SJ, Hebestreit H, Kriemler S. Radtke T, et al. Cochrane Database Syst Rev. 2017 Nov 1;11(11):CD002768. doi: 10.1002/14651858.CD002768.pub4. Cochrane Database Syst Rev. 2017. PMID: 29090734 Free PMC article. Updated. Review.
BACKGROUND: Physical exercise training may form an important part of regular care for people with cystic fibrosis. This is an update of a previously published review. OBJECTIVES: To assess the effects of physical exercise training on exercise capacity by peak oxygen consum …
BACKGROUND: Physical exercise training may form an important part of regular care for people with cystic fibrosis. This is an update …
Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review.
Shah Gupta R, Koteci A, Morgan A, George PM, Quint JK. Shah Gupta R, et al. BMJ Open Respir Res. 2023 Jun;10(1):e001291. doi: 10.1136/bmjresp-2022-001291. BMJ Open Respir Res. 2023. PMID: 37308252 Free PMC article. Review.
Randomised controlled trials, case reports and conference abstracts were excluded. 80 studies were included, the most described subgroup was autoimmune-related ILD, and the most studied conditions were rheumatoid arthritis (RA)-associated ILD, systemic sclerosis associated (SSc) …
Randomised controlled trials, case reports and conference abstracts were excluded. 80 studies were included, the most described subgroup was …
623 results